Protocol Page


	Study ID (Protocol Number)
	CA184-104


	STUDY LOCATIONS*
	Blue Ridge Cancer Care Christiansburg, VA 24073 Recruiting	Carolina Biooncology Institute Huntersville, NC 28078 Recruiting
	Cancer Centers Of The Carolinas Greenville, SC 29605 Recruiting	Clinical Research Alliance, Inc. Lake Success, NY 11042 Recruiting
	*Not all study site locations may be listed - please check back soon for updated information. For more information regarding other participating countries, please visit clinicaltrials.gov.

	STUDY NAME
	Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin
	STUDY OVERVIEW
	The purpose of the study is to determine whether Ipilimumab plus Paclitaxel and Carboplatin will extend the lives of patients with squamous only non small cell lung cancer more than placebo plus Paclitaxel and Carboplatin.

The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit ClinicalTrials.gov for complete information about this and other clinical studies.